AMRN Q2 2024 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$68M-15.7% YoY

Gross Profit

$42M62.2% margin

Operating Income

-$524,587-0.8% margin

Net Income

$2M2.3% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+19.5%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$800M

Total Liabilities

$248M

Stockholders' Equity

$552M

Cash & Equivalents

$216M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$80M	-15.7%
Gross Profit	$42M	$43M	-1.4%
Operating Income	-$524,587	-$24M	+97.8%
Net Income	$2M	-$18M	+108.7%

Revenue Segments

Product

$48M70%

Licensing And Royalty

$20M30%